Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations

Journal of Investigative Dermatology

Volumn 131, Issue 2, 2011, Pages 540-542

  Jakasa, Ivone ^a,b   Koster, Ellen S ^b   Calkoen, F ^b   McLean, W H Irwin ^c   Campbell, Linda E ^c   Bos, Jan D ^b   Verberk, Maarten M ^b   Kezic, Sanja ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FILAGGRIN; MACROGOL;

ATOPIC DERMATITIS; HUMAN; LETTER; LOSS OF FUNCTION MUTATION; NONHUMAN; PRIORITY JOURNAL; SKIN FUNCTION; SKIN PENETRATION;

EID: 78651389483     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.307     Document Type: Letter

References (16)

1. Brown SJ, McLean WH (2009) Eczema genetics: current state of knowledge and future goals. J Invest Dermatol 129:543-52
2. Chamlin SL, Kao J, Freiden IJ et al. (2002) Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 47:198-208
3. Gupta J, Grube E, Ericksen MB et al. (2008) Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. J Allergy Clin Immunol 121:725-30
4. Hanifin JM, Thurston M, Omoto M, et al., the EASI Evaluator Group (2001) The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Exp Dermatol 10:11-8
5. Hata M, Tokura Y, Takigawa M et al. (2002) Assessment of epidermal barrier function by photoacoustic spectrometry in relation to its importance in the pathogenesis of atopic dermatitis. Lab Invest 82:1451-61
6. Hubiche T, Ged C, Benard A et al. (2007) Analysis of SPINK 5, KLK 7 and FLG genotypes in a French atopic dermatitis cohort. Acta Derm Venereol 87:499-505
7. Jakasa I, De Jongh CM, Verberk MM et al. (2006) Percutaneous penetration of sodium lauryl sulphate is increased in uninvolved skin of atopic dermatitis patients compared to control subjects. Br J Dermatol 155:104-9
8. Jakasa I, Verberk MM, Esposito M et al. (2007) Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients. J invest Dermatol 127:129-34
9. Jensen JM, Pfeiffer S, Witt M et al. (2009) Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol 124(3 Suppl 2):R19-28
10. Jungersted JM, Scheer H, Mempel M et al. (2010) Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy 65:911-8
11. Kezic S, Kemperman PM, Koster ES et al. (2008) Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol 128:2117-9
12. Nemoto-Hasebe I, Akiyama M, Nomura T et al. (2009) Clinical severity correlates with impaired barrier in filaggrin-related eczema. J Invest Dermatol 129:682-9
13. O'Regan GM, Sandilands A, McLean WH et al. (2009) Filaggrin in atopic dermatitis. J Allergy Clin Immunol 124:R2-6
14. Proksch E, Brandner JM, Jensen JM (2008) The skin-an indispensable barrier. Exp Dermatol 17:1063-72
15. Sandilands A, Smith FJ, Irvine AD et al. (2007) Filaggrin's fuller figure: a glimpse into the genetic architecture of atopic dermatitis. J Invest Dermatol 127:1282-4
16. Scharschmidt TC, Man MQ, Hatano Y et al. (2009) Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol 124:496-506